Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 4
2017 3
2018 4
2019 3
2020 2
2021 8
2022 6
2023 9
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Bhatla N, Joshi S, Pimple S, Kawade A, Balasubramani L, Thomas A, Suri V, Lalwani S, Uday R, Kamath V, Mandal R, Rajeswar A, Peedicayil A, Poli UR, Banerjee D, Sankaranarayanan R, Basu P, Muwonge R, Gairola S, Dogar V, Rao H, Shaligram U. Sharma H, et al. Among authors: kawade a. Lancet Oncol. 2023 Dec;24(12):1321-1333. doi: 10.1016/S1470-2045(23)00480-1. Epub 2023 Nov 7. Lancet Oncol. 2023. PMID: 37949086 Clinical Trial.
Evaluation of acetone as a solvent for the Ames test.
Shibata T, Yamagata T, Kawade A, Asakura S, Toritsuka N, Koyama N, Hakura A. Shibata T, et al. Among authors: kawade a. Genes Environ. 2020 Jan 23;42:3. doi: 10.1186/s41021-020-0143-6. eCollection 2020. Genes Environ. 2020. PMID: 31998422 Free PMC article.
Compensation in Neonatal Clinical Trials: A Perspective.
Mathur A, Raja D, Sinha A, Gupta SS, Gupta YK, Kawade AS, Poluru R; The ProSPoNS Trial Group. Mathur A, et al. Among authors: kawade as. Indian Pediatr. 2024 May 15;61(5):469-474. Epub 2024 Mar 19. Indian Pediatr. 2024. PMID: 38517006 Free article.
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.
Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Kawade A, Lalwani S, Ravi MD, Kamath V, Mahopatra J, Kulkarni G, Tayade D, Ramanan PV, Uttam KG, Rawal L, Gawande A, Kumar NR, Tiple N, Vagha J, Thakkar P, Khandgave P, Deshmukh BJ, Agarwal A, Dogar V, Gautam M, Jaganathan KS, Kumar R, Sharma I, Gairola S. Sharma H, et al. Among authors: kawade a. NPJ Vaccines. 2024 Feb 22;9(1):41. doi: 10.1038/s41541-024-00828-w. NPJ Vaccines. 2024. PMID: 38383584 Free PMC article.
Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial.
Sinha AP, Gupta SS, Poluru R, Raut AV, Arora NK, Pandey RM, Sahu AR, Bethou A, Sazawal S, Parida S, Bavdekar A, Saili A, Gaind R, Kapil A, Garg BS, Maliye C, Jain M, Mahajan KS, Dhingra P, Pradhan KC, Kawade AS, Nangia S, Mukherjee A, Rasaily R, Sharma RS; ProSPoNS study Group. Sinha AP, et al. Among authors: kawade as. Trials. 2021 Apr 1;22(1):242. doi: 10.1186/s13063-021-05193-w. Trials. 2021. PMID: 33794969 Free PMC article.
Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
Kanungo S, Chatterjee P, Bavdekar A, Murhekar M, Babji S, Garg R, Samanta S, Nandy RK, Kawade A, Boopathi K, Kanagasabai K, Kamal VK, Kumar VS, Gupta N, Dutta S. Kanungo S, et al. Among authors: kawade a. Lancet Infect Dis. 2022 Aug;22(8):1191-1199. doi: 10.1016/S1473-3099(22)00161-X. Epub 2022 May 16. Lancet Infect Dis. 2022. PMID: 35588754 Free PMC article. Clinical Trial.
Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India.
Mangarule S, Siddaiah P, Kawade A, Dhati RM, Padmavathi IV, Palkar S, Tripathi V, Singh R, Palvi K, Mitra M, Shetty R, Leclercq J, Midde VJ, Varghese K, Kandukuri SR, Kukian D, Noriega F. Mangarule S, et al. Among authors: kawade a. Pediatr Infect Dis J. 2023 Dec 1;42(12):1128-1135. doi: 10.1097/INF.0000000000004118. Epub 2023 Oct 13. Pediatr Infect Dis J. 2023. PMID: 37851978
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study.
Mangarule S, Prashanth S, Kawade A, Ravi MD, Padmavathi IV, Palkar S, Tripathi VN, Singh R, Maurya M, Mitra M, Shetty RS, Kompithra RZ, Dhaded SM, Epari V, Moureau A, Jayanth MV, Varghese K, Ravinuthala S, Kukian D, Patnaik BN, Noriega F. Mangarule S, et al. Among authors: kawade a. Vaccine X. 2022 Sep 13;12:100216. doi: 10.1016/j.jvacx.2022.100216. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36164460 Free PMC article.
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
Kawade A, Babji S, Kamath V, Raut A, Kumar CM, Kundu R, Venkatramanan P, Lalwani SK, Bavdekar A, Juvekar S, Dayma G, Patil R, Kulkarni M, Hegde A, Nayak D, Garg BS, Gupta S, Jategaonkar S, Bedi N, Maliye C, Ganguly N, Uttam KG, Niyogi P, Palkar S, Hanumante N, Goyal N, Arya A, Aslam M, Parulekar V, Dharmadhikari A, Gaikwad D, Zade J, Desai S, Kang G, Kulkarni PS. Kawade A, et al. Vaccine. 2019 May 1;37(19):2554-2560. doi: 10.1016/j.vaccine.2019.03.067. Epub 2019 Apr 4. Vaccine. 2019. PMID: 30955982 Clinical Trial.
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Rathi N, Desai S, Kawade A, Venkatramanan P, Kundu R, Lalwani SK, Dubey AP, Venkateswara Rao J, Narayanappa D, Ghildiyal R, Gogtay N, Venugopal P, Palkar S, Munshi R, Kang G, Babji S, Bavdekar A, Juvekar S, Ganguly N, Niyogi P, Ghosh Uttam K, Rajani HS, Kondekar A, Kumbhar D, Mohanlal S, Agarwal MC, Shetty P, Antony K, Gunale B, Dharmadhikari A, Tang Y, Kulkarni PS, Flores J. Rathi N, et al. Among authors: kawade a. Vaccine. 2018 Dec 18;36(52):7943-7949. doi: 10.1016/j.vaccine.2018.11.006. Epub 2018 Nov 9. Vaccine. 2018. PMID: 30420116 Free PMC article. Clinical Trial.
47 results